Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sergei Shevtsov

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|March 9, 2002
Crystal structure of the human estrogen sulfotransferase-PAPS complex: evidence for catalytic role of Ser137 in the sulfuryl transfer reactionLars C Pedersen, Evgeniy Petrotchenko, Sergei Shevtsov, et al.
Environmental Health Perspectives|June 5, 2003
Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferaseSergei Shevtsov, Evgeniy V Petrotchenko, Lars C Pedersen, et al.
Nano Letters|April 23, 2025
Multifunctional Meta-optic Azimuthal Shear InterferometerLinzhi Yu, Sergei Shevtsov, Haobijam Johnson Singh, et al.
Nature Medicine|July 25, 2006
Cardiotoxicity of the cancer therapeutic agent imatinib mesylateRisto Kerkelä, Luanda Grazette, Rinat Yacobi, et al.
Nature Communications|February 9, 2021
Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypesBradley A Maron, Rui-Sheng Wang, Sergei Shevtsov, et al.
Nature Communications|November 17, 2022
Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypesBradley A Maron, Rui-Sheng Wang, Sergei Shevtsov, et al.
Nature Communications|April 8, 2024
Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypesBradley A Maron, Rui-Sheng Wang, Sergei Shevtsov, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|March 9, 2002
Crystal structure of the human estrogen sulfotransferase-PAPS complex: evidence for catalytic role of Ser137 in the sulfuryl transfer reactionLars C Pedersen, Evgeniy Petrotchenko, Sergei Shevtsov, et al.
Environmental Health Perspectives|June 5, 2003
Crystallographic analysis of a hydroxylated polychlorinated biphenyl (OH-PCB) bound to the catalytic estrogen binding site of human estrogen sulfotransferaseSergei Shevtsov, Evgeniy V Petrotchenko, Lars C Pedersen, et al.
Nano Letters|April 23, 2025
Multifunctional Meta-optic Azimuthal Shear InterferometerLinzhi Yu, Sergei Shevtsov, Haobijam Johnson Singh, et al.
Nature Medicine|July 25, 2006
Cardiotoxicity of the cancer therapeutic agent imatinib mesylateRisto Kerkelä, Luanda Grazette, Rinat Yacobi, et al.
Nature Communications|February 9, 2021
Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypesBradley A Maron, Rui-Sheng Wang, Sergei Shevtsov, et al.
Nature Communications|November 17, 2022
Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypesBradley A Maron, Rui-Sheng Wang, Sergei Shevtsov, et al.
Nature Communications|April 8, 2024
Author Correction: Individualized interactomes for network-based precision medicine in hypertrophic cardiomyopathy with implications for other clinical pathophenotypesBradley A Maron, Rui-Sheng Wang, Sergei Shevtsov, et al.
Pageof 1